Horizon Scanning
Navigate Up
Sign In

Horizon Scanning

Horizon scanning is the process which allows the identification of new and emerging medical products via systematic analysis of pipeline health technologies, typically before both market entry and the HTA process. Early identification of new medicines enables assessment of their potential relevance and impact on the healthcare system, besides the identification of possible threats and opportunities, thus allowing for pro-active policymaking and better budgetary planning.​

A horizon scanning system was established within the Pharmaceutical Policy and EU Affairs Unit in 2020 with the aim of performing horizon scanning activities within the context of pharmaceutical policy. The horizon scanning system at DPA aims to improve strategic financial planning and decision-making by providing early intelligence on new medicines which are not yet licensed.

For further information please contact us on dpa.strategyandpolicy@gov.mt